N
Nautilus Biotechnolgy D
D
NAUT
2.30000
USD
0.06
(2.45%)
Market Closed
Volume
1,526
EPS
-1
Div Yield
-
P/E
-4
Market Cap
288,797,120
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Nautilus Biotechnolgy
Sector: Healthcare
Industry: Biotechnology
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.